Cardiovascular magnetic resonance imaging: What the general cardiologist should know

Heart

Volumn 102, Issue 19, 2016, Pages 1589-1603

  Ripley, D P ^a   Musa, T A ^a   Dobson, L E ^a   Plein, S ^a   Greenwood, J P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE; GADOLINIUM; NICORANDIL; REGADENOSON;

ACUTE HEART INFARCTION; ADULT CONGENITAL HEART DISEASE; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLOOD FLOW VELOCITY; BOLD SIGNAL; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PROCEDURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ANGIOGRAPHY; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DEFIBRILLATOR; DEVICE SAFETY; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FALSE ANEURYSM; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART CYCLE; HEART EDEMA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE ISCHEMIA; HEART TUMOR; HEART VALVE PROSTHESIS; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMAGE QUALITY; INOTROPIC STRESS; INTRAMYOCARDIAL HEMORRHAGE; LIMIT OF QUANTITATION; MAGNETIC RESONANCE ANGIOGRAPHY; MEDIASTINUM LYMPHADENOPATHY; MICROVASCULAR OBSTRUCTION; MYOCARDIAL EDEMA; NONISCHEMIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE SCANNER; PACEMAKER; PERICARDIAL EFFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VALVE INSUFFICIENCY; RADIOFREQUENCY; REVASCULARIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TAKOTSUBO CARDIOMYOPATHY; THROMBUS; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULAR HEART DISEASE; VASCULAR CLOSURE DEVICE; VASODILATORY STRESS; ATTITUDE TO HEALTH; DIAGNOSTIC IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PREDICTIVE VALUE; PROGNOSIS; PSYCHOLOGY; REPRODUCIBILITY; RISK ASSESSMENT;

CARDIOLOGISTS; CARDIOVASCULAR DISEASES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 84984653346     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-307896     Document Type: Article

References (132)

1. Dastidar AG, Rodrigues JC, Baritussio A, et al. MRI in the assessment of ischaemic heart disease. Heart 2016; 102: 239-52
2. Bruder O, Wagner A, Lombardi M, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry-multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson 2013; 15: 9
3. Flett AS, Westwood MA, Davies LC, et al. The prognostic implications of cardiovascular magnetic resonance. Circ Cardiovasc Imaging 2009; 2: 243-50
4. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012; 126: e354-471
5. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003
6. National Institute for Health and Care Excellence (NICE) (2010). Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Clinical Guideline 95. London: National Institute for Health and Care Excellence
7. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-847
8. Petersen SE, Almeida AG, Alpendurada F, et al. Update of the European Association of Cardiovascular Imaging (EACVI) Core Syllabus for the European Cardiovascular Magnetic Resonance Certification Exam. Eur Heart J Cardiovasc Imaging 2014; 15: 728-9
9. Pohost GM, Kim RJ, Kramer CM, et al. Task Force 12: training in advanced cardiovascular imaging (cardiovascular magnetic resonance [CMR]): endorsed by the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2006; 47: 910-14
10. Kim RJ, De Roos A, Fleck E, et al. Guidelines for training in Cardiovascular Magnetic Resonance (CMR). J Cardiovasc Magn Reson 2007; 9: 3-4
11. Ripley DP, Sado D, McCann G, et al. Cardiovascular magnetic resonance activity in the United Kingdom: results of the 2014 bscmr survey. Heart 2015; 101(Suppl 2): A14-15
12. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004; 25: 1940-65
13. Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson 2010; 12: 71
14. Herfkens RJ, Higgins CB, Hricak H, et al. Nuclear magnetic resonance imaging of the cardiovascular system: normal and pathologic findings. Radiology 1983; 147: 749-59
15. Bradley WG Jr, Waluch V, Lai KS, et al. The appearance of rapidly flowing blood on magnetic resonance images. AJR Am J Roentgenol 1984; 143: 1167-74
16. Axel L, Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology 1989; 171: 841-5
17. Swoboda PP, Larghat A, Zaman A, et al. Reproducibility of myocardial strain and left ventricular twist measured using complementary spatial modulation of magnetization. J Magn Reson Imaging 2014; 39: 887-94
18. Khan JN, Singh A, Nazir SA, et al. Comparison of cardiovascular magnetic resonance feature tracking and tagging for the assessment of left ventricular systolic strain in acute myocardial infarction. Eur J Radiol 2015; 84: 840-8
19. Biglands JD, Radjenovic A, Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: Part II. J Cardiovasc Magn Reson 2012; 14: 66
20. Myerson SG, d?Arcy J, Mohiaddin R, et al. Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation 2012; 126: 1452-60
21. Defrance C, Bollache E, Kachenoura N, et al. Evaluation of aortic valve stenosis using cardiovascular magnetic resonance: comparison of an original semiautomated analysis of phase-contrast cardiovascular magnetic resonance with Doppler echocardiography. Circ Cardiovasc Imaging 2012; 5: 604-12
22. Lanzer P, Barta C, Botvinick EH, et al. ECG-synchronized cardiac MR imaging: method and evaluation. Radiology 1985; 155: 681-6
23. Lenz GW, Haacke EM, White RD. Retrospective cardiac gating: a review of technical aspects and future directions. Magn Reson Imaging 1989; 7: 445-55
24. Raj V, Agrawal SK. Ischaemic heart disease assessment by cardiovascular magnetic resonance imaging. Postgrad Med J 2010; 86: 532-40
25. Ferreira PF, Gatehouse PD, Mohiaddin RH, et al. Cardiovascular magnetic resonance artefacts. J Cardiovasc Magn Reson 2013; 15: 41
26. Kanal E, Barkovich AJ, Bell C, et al., Expert Panel on MRS. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging 2013; 37: 501-30
27. Hussain ST, Paul M, Plein S, et al. Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson 2012; 14: 65
28. Dill T. Contraindications to magnetic resonance imaging: non-invasive imaging. Heart 2008; 94: 943-8
29. Strich G, Hagan PL, Gerber KH, et al. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA. Radiology 1985; 154: 723-6
30. Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-Analysis. AJR Am J Roentgenol 1991; 156: 825-32
31. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359-62
32. Sachs HC, Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics 2013; 132: e796-809
33. Hundley WG, Bluemke DA, Finn JP, et al., American College of Cardiology Foundation Task Force on Expert Consensus Documents. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010; 55: 2614-62
34. Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012; 379: 453-60
35. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J 2013; 34: 775-81
36. Jaarsma C, Leiner T, Bekkers SC, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-Analysis. J Am Coll Cardiol 2012; 59: 1719-28
37. Coelho-Filho OR, Seabra LF, Mongeon FP, et al. Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient?s sex. JACC Cardiovasc Imaging 2011; 4: 850-61
38. Greenwood JP, Herzog BA, Brown JM, et al. Prognostic value of cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease: long-term follow-up of a prospective, diagnostic accuracy cohort study. Ann Intern Med 2016; 165: 1-9
39. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?. Eur Heart J 2000; 21: 1387-96
40. Lubbers DD, Janssen CH, Kuijpers D, et al. The additional value of first pass myocardial perfusion imaging during peak dose of dobutamine stress cardiac MRI for the detection of myocardial ischemia. Int J Cardiovasc Imaging 2008; 24: 69-76
41. Charoenpanichkit C, Hundley WG. The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010; 12: 59
42. Ripley DP, Motwani M, Brown JM, et al. Individual component analysis of the multi-parametric cardiovascular magnetic resonance protocol in the CE-MARC trial. J Cardiovasc Magn Reson 2015; 17: 59
43. Klein C, Gebker R, Kokocinski T, et al. Combined magnetic resonance coronary artery imaging, myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease. J Cardiovasc Magn Reson 2008; 10: 45
44. Ripley DP, Saha A, Teis A, et al. The distribution and prognosis of anomalous coronary arteries identified by cardiovascular magnetic resonance: 15 year experience from two tertiary centres. J Cardiovasc Magn Reson 2014; 16: 34
45. Walker S, Girardin F, McKenna C, et al. Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study. Heart 2013; 99: 873-81
46. Boldt J, Leber AW, Bonaventura K, et al. Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany. J Cardiovasc Magn Reson 2013; 15: 30
47. Moschetti K, Muzzarelli S, Pinget C, et al. Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss, and United States health care systems. J Cardiovasc Magn Reson 2012; 14: 35
48. Maredia N, Radjenovic A, Kozerke S, et al. Effect of improving spatial or temporal resolution on image quality and quantitative perfusion assessment with k-t SENSE acceleration in first-pass CMR myocardial perfusion imaging. Magn Reson Med 2010; 64: 1616-24
49. Motwani M, Kidambi A, Greenwood JP, et al. Advances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies. Heart 2014; 100: 1722-33
50. Fair MJ, Gatehouse PD, DiBella EV, et al. A review of 3D first-pass, whole-heart, myocardial perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2015; 17: 68
51. Manka R, Paetsch I, Schnackenburg B, et al. BOLD cardiovascular magnetic resonance at 3.0 tesla in myocardial ischemia. J Cardiovasc Magn Reson 2010; 12: 54
52. Zun Z, Varadarajan P, Pai RG, et al. Arterial spin labeled CMR detects clinically relevant increase in myocardial blood flow with vasodilation. JACC Cardiovasc Imaging 2011; 4: 1253-61
53. Plein S, Greenwood JP, Ridgway JP, et al. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004; 44: 2173-81
54. National Horizon Scanning Centre. Myocardial stress perfusion magnetic resonance imaging (MRI) assessment of myocardial blood flow in coronary artery disease. April 2007. http: //www. hsric.nihr.ac.uk/topics/myocardial-stress-perfusion-magneticresonance-imaging-for-the-Assessment-of-myocardial-blood-flowin-coronary-Artery-disease/
55. Greenwood JP, Younger JF, Ridgway JP, et al. Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart 2007; 93: 1363-8
56. Abdel-Aty H, Cocker M, Meek C, et al. Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol 2009; 53: 1194-201
57. Friedrich MG, Abdel-Aty H, Taylor A, et al. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1581-7
58. Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004; 109: 2411-16
59. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010; 55: 2470-9
60. Mather AN, Lockie T, Nagel E, et al. Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2009; 11: 33
61. Gerber BL, Rochitte CE, Melin JA, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000; 101: 2734-41
62. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-72
63. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005; 26: 549-57
64. Choi CJ, Haji-Momenian S, Dimaria JM, et al. Infarct involution and improved function during healing of acute myocardial infarction: the role of microvascular obstruction. J Cardiovasc Magn Reson 2004; 6: 917-25
65. Nijveldt R, Beek AM, Hirsch A, et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008; 52: 181-9
66. Ganame J, Messalli G, Dymarkowski S, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009; 30: 1440-9
67. O?Regan DP, Ahmed R, Karunanithy N, et al. Reperfusion hemorrhage following acute myocardial infarction: assessment with T2∗ mapping and effect on measuring the area at risk. Radiology 2009; 250: 916-22
68. Eitel I, Kubusch K, Strohm O, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging 2011; 4: 354-62
69. Mollet NR, Dymarkowski S, Volders W, et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 2002; 106: 2873-6
70. Weinsaft JW, Kim HW, Crowley AL, et al. LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging 2011; 4: 702-12
71. Artis NJ, Thomson J, Plein S, et al. Percutaneous closure of postinfarction ventricular septal defect: cardiac magnetic resonance-guided case selection and postprocedure evaluation. Can J Cardiol 2011; 27: 869.e3-5
72. Jensen CJ, Jochims M, Hunold P, et al. Right ventricular involvement in acute left ventricular myocardial infarction: prognostic implications of MRI findings. AJR Am J Roentgenol 2010; 194: 592-8
73. Assomull RG, Lyne JC, Keenan N, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007; 28: 1242-9
74. Gerbaud E, Harcaut E, Coste P, et al. Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Int J Cardiovasc Imaging 2012; 28: 783-94
75. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31: 1040-8
76. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-53
77. Romero J, Xue X, Gonzalez W, et al. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-Analysis of prospective trials. JACC Cardiovasc Imaging 2012; 5: 494-508
78. Shah DJ, Kim HW, James O, et al. Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA 2013; 309: 909-18
79. Glaveckaite S, Valeviciene N, Palionis D, et al. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation. J Cardiovasc Magn Reson 2011; 13: 35
80. Choi KM, Kim RJ, Gubernikoff G, et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001; 104: 1101-7
81. Anderson LJ, Wonke B, Prescott E, et al. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 2002; 360: 516-20
82. Kirk P, Roughton M, Porter JB, et al. Cardiac T2∗ magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009; 120: 1961-8
83. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008; 51: 2414-21
84. Lehrke S, Lossnitzer D, Schöb M, et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011; 97: 727-32
85. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48: 1977-85
86. Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013; 309: 896-908
87. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1369-74
88. Briasoulis A, Mallikethi-Reddy S, Palla M, et al. Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-Analysis. Heart 2015; 101: 1406-11
89. Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 2014; 130: 484-95
90. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 1969-77
91. Patel AR, Klein MR, Chandra S, et al. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail 2011; 13: 1231-7
92. Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013; 6: 501-11
93. Dungu JN, Valencia O, Pinney JH, et al. CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging 2014; 7: 133-42
94. Fontana M, Pica S, Reant P, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2015; 132: 1570-9
95. Banypersad SM, Fontana M, Maestrini V, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 2015; 36: 244-51
96. Maceira AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008; 10: 54
97. Sado DM, White SK, Piechnik SK, et al. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 2013; 6: 392-8
98. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010; 31: 806-14
99. Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012; 59: 1604-15
100. Parsai C, O?Hanlon R, Prasad SK, et al. Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson 2012; 14: 54
101. Savage DD, Garrison RJ, Brand F, et al. Prevalence and correlates of posterior extra echocardiographic spaces in a free-living population based sample (the Framingham study). Am J Cardiol 1983; 51: 1207-12
102. Verhaert D, Gabriel RS, Johnston D, et al. The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging 2010; 3: 333-43
103. Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson 2009; 11: 14
104. Bogaert J, Francone M. Pericardial disease: value of CT and MR imaging. Radiology 2013; 267: 340-56
105. Sechtem U, Tscholakoff D, Higgins CB. MRI of the normal pericardium. AJR Am J Roentgenol 1986; 147: 239-44
106. Francone M, Dymarkowski S, Kalantzi M, et al. Real-time cine MRI of ventricular septal motion: a novel approach to assess ventricular coupling. J Magn Reson Imaging 2005; 21: 305-9
107. Kojima S, Yamada N, Goto Y. Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging. N Engl J Med 1999; 341: 373-4
108. Moore AG, Eagle KA, Bruckman D, et al. Choice of computed tomography, transesophageal echocardiography, magnetic resonance imaging, and aortography in acute aortic dissection: International Registry of Acute Aortic Dissection (IRAD). Am J Cardiol 2002; 89: 1235-8
109. Burman ED, Keegan J, Kilner PJ. Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc Imaging 2008; 1: 104-13
110. Kawamoto S, Bluemke DA, Traill TA, et al. Thoracoabdominal aorta in Marfan syndrome: MR imaging findings of progression of vasculopathy after surgical repair. Radiology 1997; 203: 727-32
111. Sivananthan UM, Ridgway JP, Bann K, et al. Fast magnetic resonance angiography using turbo-FLASH sequences in advanced aortoiliac disease. Br J Radiol 1993; 66: 1103-10
112. Litmanovich D, Bankier AA, Cantin L, et al. CT and MRI in diseases of the aorta. AJR Am J Roentgenol 2009; 193: 928-40
113. Kato R, Lickfett L, Meininger G, et al. Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons learned by use of magnetic resonance imaging. Circulation 2003; 107: 2004-10
114. Reant P, Lederlin M, Lafitte S, et al. Absolute assessment of aortic valve stenosis by planimetry using cardiovascular magnetic resonance imaging: comparison with transesophageal echocardiography, transthoracic echocardiography, and cardiac catheterisation. Eur J Radiol 2006; 59: 276-83
115. Lanjewar C, Ephrem B, Mishra N, et al. Planimetry of mitral valve stenosis in rheumatic heart disease by magnetic resonance imaging. J Heart Valve Dis 2010; 19: 357-63
116. Pouleur AC, le Polain De Waroux JB, Pasquet A, et al. Planimetric and continuity equation assessment of aortic valve area: Head to head comparison between cardiac magnetic resonance and echocardiography. J Magn Reson Imaging 2007; 26: 1436-43
117. Cawley PJ, Hamilton-Craig C, Owens DS, et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging 2013; 6: 48-57
118. Vliegen HW, Van Straten A, De Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. Circulation 2002; 106: 1703-7
119. Uretsky S, Gillam L, Lang R, et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol 2015; 65: 1078-88
120. Fairbairn TA, Steadman CD, Mather AN, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart 2013; 99: 1185-91
121. Shah DJ. Cardiac magnetic resonance for mitral regurgitation diagnosis: when is it needed?. Curr Opin Cardiol 2012; 27: 485-91
122. Aplin M, Kyhl K, Bjerre J, et al. Cardiac remodelling and function with primary mitral valve insufficiency studied by magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 2016; 17: 863-70
123. Pazos-López P, Pozo E, Siqueira ME, et al. Value of CMR for the differential diagnosis of cardiac masses. JACC Cardiovasc Imaging 2014; 7: 896-905
124. Motwani M, Kidambi A, Herzog BA, et al. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology 2013; 268: 26-43
125. Elbardissi AW, Dearani JA, Daly RC, et al. Survival after resection of primary cardiac tumors: a 48-year experience. Circulation 2008; 118(14 Suppl): S7-15
126. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-57
127. Kilner PJ, Geva T, Kaemmerer H, et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J 2010; 31: 794-805
128. Oosterhof T, Van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007; 116: 545-51
129. Ripley DP, Brown JM, Everett CC, et al. Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): a prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease. Am Heart J 2015; 169: 17-24.e1
130. Kramer CM, Appelbaum E, Desai MY, et al. Hypertrophic cardiomyopathy registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy. Am Heart J 2015; 170: 223-30
131. Wong TC, Piehler K, Meier CG, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012; 126: 1206-16
132. Moon JC, Messroghli DR, Kellman P, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013; 15: 92